Pivotal Phase 3 Trials of Oral Simufilam Planned for Year’s End
News
Cassava Sciences plans to launch two Phase 3 clinical trials evaluating the efficacy of simufilam, its investigational oral treatment for Alzheimer’s disease, in the second half of this year, ... Read more